Teladoc Health (NYSE:TDOC) Shares Up 7.5% - Time to Buy?

Key Points

• Teladoc Health's stock increased by 7.5% during mid-day trading, reaching $8.39, following a previous close of $7.80.
• Analysts maintain a mixed outlook on Teladoc, with six ratings as "Buy" and eleven as "Hold," resulting in an average price target of $9.80.
• Despite beating earnings expectations with a reported EPS of ($0.19), Teladoc's revenue decreased by 1.6% year-over-year, indicating ongoing financial challenges.

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) shares were up 7.5% during mid-day trading on Thursday . The stock traded as high as $8.36 and last traded at $8.39. Approximately 3,647,433 shares traded hands during mid-day trading, a decline of 45% from the average daily volume of 6,686,834 shares. The stock had previously closed at $7.80.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on TDOC shares. Mizuho initiated coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price target on the stock. Evercore ISI upped their price target on Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a research report on Wednesday, July 9th. Six analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $9.80.

Teladoc Health Stock Up 8.5%

The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58. The stock has a fifty day moving average price of $7.64 and a two-hundred day moving average price of $7.60. The company has a market cap of $1.50 billion, a P/E ratio of -7.11 and a beta of 1.90.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.Teladoc Health's revenue was down 1.6% on a year-over-year basis. During the same period last year, the business posted ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently added to or reduced their stakes in TDOC. Vanguard Group Inc. lifted its stake in Teladoc Health by 7.0% during the first quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock worth $157,229,000 after purchasing an additional 1,289,183 shares during the last quarter. Geode Capital Management LLC boosted its position in Teladoc Health by 2.1% during the 2nd quarter. Geode Capital Management LLC now owns 4,150,197 shares of the health services provider's stock valued at $36,153,000 after acquiring an additional 84,356 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Teladoc Health by 5.2% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,571,673 shares of the health services provider's stock valued at $20,471,000 after acquiring an additional 127,960 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Teladoc Health by 14.8% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,558,369 shares of the health services provider's stock worth $12,405,000 after purchasing an additional 200,494 shares in the last quarter. Finally, Nuveen LLC bought a new stake in shares of Teladoc Health in the 1st quarter worth approximately $11,789,000. Institutional investors own 76.82% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.